NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 135 filers reported holding NEKTAR THERAPEUTICS in Q4 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $300,000 | +23.0% | 24,457 | +37.9% | 0.08% | +128.6% |
| Q1 2016 | $244,000 | -61.0% | 17,736 | -52.2% | 0.04% | -47.8% |
| Q4 2015 | $625,000 | -81.2% | 37,093 | -86.1% | 0.07% | -79.4% |
| Q2 2015 | $3,327,000 | +649.3% | 265,960 | +622.3% | 0.32% | +755.3% |
| Q3 2014 | $444,000 | -35.1% | 36,822 | -30.9% | 0.04% | -29.6% |
| Q2 2014 | $684,000 | -85.0% | 53,318 | -85.9% | 0.05% | -82.1% |
| Q1 2014 | $4,571,000 | +52.5% | 377,155 | +31.4% | 0.30% | +120.4% |
| Q3 2013 | $2,998,000 | +28.6% | 287,048 | +42.2% | 0.14% | +39.8% |
| Q2 2013 | $2,332,000 | – | 201,929 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |